Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our Best Content in Your Email

You are already a member! Please enter your password to sign in.

Columnists


About Allan Jackson

Allan Jackson
Allan Jackson
Allan Jackson is a graduate of Dartmouth College, and a former investment banker with J.P Morgan. He currently works for J. Lazarow & Co., a ...


Allan Jackson's Most Recent Articles

Auspicious developments at pharmaceutical company

Writer says Cellceutix Corp. has made what appears to be a breakthrough in oncology with its...

Allan Jackson | November 4, 2011
0 stars

Micro cap biotech tackling autism treatment

Dark horse candidate developing a novel compound

Allan Jackson | July 15, 2010
0 stars

3D technology delivers heart images quickly and on the cheap

Medical devices company has years of research, managerial expertise backing it.

Allan Jackson | March 11, 2010
0 stars

Anti-viral compound could be developed for multiple usages

Micro-cap biotech company has "destructively innovative technology" and great management.

Allan Jackson | March 8, 2010
0 stars

Steel maker ready to bring new mills into production

Mining and construction industry could use new super alloy

Allan Jackson | February 9, 2010
0 stars

Biotech junior is baby blue chip

Management from major drug developers moves to nano-cap company with cancer drug in development.

Allan Jackson | September 21, 2009
0 stars